Myomo chief medical officer sells $29,895 in shares
MYOMO, INC. (NASDAQ:MYO)'s Chief Medical Officer, Harry Kovelman, divested 17,250 shares of the company's common stock on August 20, 2026, generating roughly $29,895 from the sale. The shares were traded at prices between $1.72 and $1.75 each, with the stock surging 136% over the past six months and 90% year-to-date, nearing a 52-week high of $1.89.
Post-transaction, Kovelman still owns 105,983 shares of MYOMO, INC. common stock. Analysts suggest the stock may be overvalued relative to its Fair Value. Further insights into MYO are available through InvestingPro's ProTips and detailed analysis. Meanwhile, Myomo Inc. reported that its second-quarter results exceeded Wall Street expectations, with revenue rising by 21% year over year to $11.7 million, surpassing the projected $10.29 million.
Net loss also decreased to $0.09 per share from the forecasted $0.10 per share. The company's gross margin showed significant improvement, driven by record sales of 255 MyoPro units and a bullish full-year revenue outlook, indicating a positive market trajectory for MYOMO, INC.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
